FDA Inspection 1060107 — David M. Stoll, MD

David M. Stoll, MD — FEI 3006578268

The FDA completed an inspection of David M. Stoll, MD on Jun 22, 2018 in Beverly Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 22, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Beverly Hills, CA (United States)

Additional Details

Clinical Investigator (CI)